According to Ionis Pharmaceuticals
's latest financial reports the company has $0.38 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.38 B | -32.5% |
2022-12-31 | $0.57 B | -25.77% |
2021-12-31 | $0.77 B | 3.83% |
2020-12-31 | $0.74 B | -55.88% |
2019-12-31 | $1.68 B | 41.9% |
2018-12-31 | $1.18 B | 225% |
2017-12-31 | $0.36 B | 266.88% |
2016-12-31 | $99.56 M | -50.41% |
2015-12-31 | $0.20 B | -22.11% |
2014-12-31 | $0.25 B | -31.87% |
2013-12-31 | $0.37 B | 107.04% |
2012-12-31 | $0.18 B | 6.61% |
2011-12-31 | $0.17 B | -29.9% |
2010-12-31 | $0.24 B | -19.04% |
2009-12-31 | $0.30 B | 189.76% |
2008-12-31 | $0.10 B | 917.75% |
2007-12-31 | $10.24 M | -89.54% |
2006-12-31 | $97.9 M | 3573.62% |
2005-12-31 | $2.66 M | -103.69% |
2004-12-31 | $-72.14 M | -207.38% |
2003-12-31 | $67.17 M | -56.79% |
2002-12-31 | $0.15 B | -30.31% |
2001-12-31 | $0.22 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.88 M | -100.74% | Bahamas |
NRC Health
NRC | $48.95 M | -87.34% | ๐บ๐ธ USA |